Omada Health (NASDAQ:OMDA) Now Covered by Analysts at The Goldman Sachs Group

Investment analysts at The Goldman Sachs Group assumed coverage on shares of Omada Health (NASDAQ:OMDA - Get Free Report) in a note issued to investors on Tuesday, MarketBeat reports. The firm set a "buy" rating and a $29.00 price target on the stock. The Goldman Sachs Group's price target points to a potential upside of 55.66% from the stock's current price.

OMDA has been the topic of a number of other research reports. Canaccord Genuity Group began coverage on Omada Health in a research report on Tuesday. They issued a "buy" rating and a $27.00 price target on the stock. Wall Street Zen upgraded shares of Omada Health to a "hold" rating in a research note on Monday, June 16th. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $23.57.

Omada Health Trading Up 2.9%

Shares of NASDAQ OMDA traded up $0.53 during mid-day trading on Tuesday, hitting $18.63. The company had a trading volume of 344,526 shares, compared to its average volume of 1,585,299. Omada Health has a 1-year low of $14.14 and a 1-year high of $28.40.

About Omada Health

Omada's mission is to bend the curve. Our hope is that, one day, tomorrow's epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.